EurekAlert!2d
Testing patients for just three genes could help prevent three quarters of avoidable side effects of certain medications
A new study from Queen Mary University of London found that 9% of all reported adverse drug reactions (ADRs) reported to the UK medicines regulator are associated with medications where side effect ...
Devdiscourse5d
Public Health at Risk: Fixing the Flaws in Sri Lanka’s Medicine Distribution System
A comprehensive assessment reveals that Sri Lanka’s pharmaceutical supply chain, though grounded in strong public access, ...
PharmiWeb8d
Launched at Breakthrough 2025, ArisGlobal announces LifeSphere Unify, NavaX Insights, and Advanced Compliance Docs
ArisGlobal, a leading life sciences technology company and creator of LifeSphere®, today announced three new cutting-edge product offerings that will advance pharmacovigilance and regulatory ...
Analytics India Magazine9d
Tech Mahindra, Wipro Individually Partner With NVIDIA at GTC 2025
Tech Mahindra and NVIDIA have announced a collaboration to develop an autonomous pharmacovigilance solution for improving ...
Yahoo Finance16d
Pharmacovigilance Market Forecast to Surge to $24.76 Billion by 2030, Creating Lucrative Opportunities for Digital Transformation in Drug Safety
This evolution underscores the necessity for a robust and agile pharmacovigilance system that can swiftly adapt to changes in regulatory landscapes while simultaneously embracing new data-driven ...
Frontiers27d
Post-marketing safety surveillance of vortioxetine hydrobromide: a pharmacovigilance study leveraging FAERS database
This study used the latest reported data from the FDA's Adverse Event Reporting System (FAERS) database to evaluate AEs associated with the use of vortioxetine in FAERS from Q3 2013 to Q1 2024 for ...